Evolus ROA 2016-2018 | EOLS

Current and historical return on assets (ROA) values for Evolus (EOLS) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. Evolus ROA for the three months ending September 30, 2018 was -14.93%.
Evolus ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2018-09-30 $-0.03B $0.18B -20.55%
2018-06-30 $-0.02B $0.12B -20.95%
2018-03-31 $-0.01B $0.13B -10.04%
2017-12-31 $-0.01B $0.15B -13.16%
2017-09-30 $-0.01B $0.00B -46.75%
2017-06-30 $-0.01B $0.00B -15.19%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.432B $0.000B
Evolus, Inc. is a medical aesthetics company. It focuses on providing physicians and patients in aesthetic procedures and treatments. The company focuses on the self-pay aesthetic market and its lead product candidate, DWP-450, is an injectable 900 kDa purified botulinum toxin type A complex. Evolus, Inc. is based in Irvine, California.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $119.905B 24.30
Medtronic (MDT) Ireland $113.823B 17.02
Stryker (SYK) United States $58.994B 22.24
Boston Scientific (BSX) United States $48.862B 24.69
Baxter (BAX) United States $35.185B 22.72
Zimmer Biomet Holdings (ZBH) United States $20.946B 13.58
Smith & Nephew SNATS (SNN) United Kingdom $16.239B 0.00
ResMed (RMD) United States $16.185B 30.86
Canopy Growth (CGC) Canada $9.865B 0.00
Bio-Rad Laboratories (BIO) United States $7.082B 45.28
Aurora Cannabis (ACB) Canada $6.767B 35.68
Perrigo (PRGO) Ireland $6.211B 9.43
Hill-Rom Holdings (HRC) United States $6.208B 19.42
Haemonetics (HAE) United States $5.043B 44.35
ICU Medical (ICUI) United States $4.661B 25.97
Insulet (PODD) United States $4.392B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.738B 0.00
Agios Pharmaceuticals (AGIO) United States $3.164B 0.00
Neogen (NEOG) United States $3.027B 46.50
Hutchison China MediTech (HCM) China $2.828B 0.00
National Vision Holdings (EYE) United States $2.347B 45.40
NuVasive (NUVA) United States $2.316B 21.55
Quidel (QDEL) United States $2.044B 26.65
NxStage Medical (NXTM) United States $1.917B 0.00
Aphria (APHA) $1.761B 78.33
Phibro Animal Health (PAHC) United States $1.288B 18.23
AtriCure (ATRC) United States $1.141B 0.00
VAREX IMAGING (VREX) United States $0.981B 19.65
Cardiovascular Systems (CSII) United States $0.966B 1390.00
Cerus (CERS) United States $0.767B 0.00
OraSure Technologies (OSUR) United States $0.731B 41.14
Meridian Bioscience (VIVO) United States $0.710B 22.64
PetIQ (PETQ) United States $0.695B 18.02
NanoString Technologies (NSTG) United States $0.668B 0.00
Surmodics (SRDX) United States $0.632B 95.67
Lantheus Holdings (LNTH) United States $0.627B 19.39
Omeros (OMER) United States $0.619B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.616B 19.76
MacroGenics (MGNX) United States $0.571B 0.00
Quanterix (QTRX) United States $0.488B 0.00
Owens & Minor (OMI) United States $0.468B 5.29
LeMaitre Vascular (LMAT) United States $0.453B 22.25
TG Therapeutics (TGTX) United States $0.380B 0.00
Insys Therapeutics (INSY) United States $0.327B 0.00
Utah Medical Products (UTMD) United States $0.311B 20.10
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.302B 0.00
Vapotherm (VAPO) United States $0.281B 0.00
Bovie Medical (APYX) United States $0.274B 0.00
BioLife Solutions (BLFS) United States $0.228B 307.75
Cytosorbents (CTSO) United States $0.223B 0.00
Rockwell Medical (RMTI) United States $0.175B 0.00
Chimerix (CMRX) United States $0.151B 0.00
Surface Oncology (SURF) United States $0.139B 0.00
Fonar (FONR) United States $0.130B 6.53
Chembio Diagnostics (CEMI) United States $0.116B 0.00
United-Guardian (UG) United States $0.093B 19.56
Female Health (VERU) United States $0.085B 0.00
InfuSystems Holdings (INFU) United States $0.066B 0.00
Trinity Biotech (TRIB) Ireland $0.064B 17.87
Oramed Pharmaceuticals (ORMP) United States $0.059B 0.00
CAS Medical Systems (CASM) United States $0.057B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.056B 0.00
ImmuCell (ICCC) United States $0.039B 0.00
Neurotrope (NTRP) United States $0.032B 0.00
Capricor Therapeutics (CAPR) United States $0.020B 0.00
Myomo (MYO) United States $0.019B 0.00
Senestech (SNES) United States $0.019B 0.00
Akers Biosciences Inc (AKER) United States $0.017B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.014B 0.00
Valeritas Holdings (VLRX) United States $0.010B 0.00
Cellectar Biosciences (CLRB) United States $0.009B 0.00
NeuroMetrix (NURO) United States $0.008B 0.00